189 related articles for article (PubMed ID: 18505924)
1. Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies.
Corcoran CA; He Q; Ponnusamy S; Ogretmen B; Huang Y; Sheikh MS
Mol Cancer Res; 2008 May; 6(5):795-807. PubMed ID: 18505924
[TBL] [Abstract][Full Text] [Related]
2. Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein.
Krut O; Wiegmann K; Kashkar H; Yazdanpanah B; Krönke M
J Biol Chem; 2006 May; 281(19):13784-13793. PubMed ID: 16517606
[TBL] [Abstract][Full Text] [Related]
3. Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle.
Moylan JS; Smith JD; Wolf Horrell EM; McLean JB; Deevska GM; Bonnell MR; Nikolova-Karakashian MN; Reid MB
Redox Biol; 2014; 2():910-20. PubMed ID: 25180167
[TBL] [Abstract][Full Text] [Related]
4. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
[TBL] [Abstract][Full Text] [Related]
6. P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest.
Shamseddine AA; Clarke CJ; Carroll B; Airola MV; Mohammed S; Rella A; Obeid LM; Hannun YA
Cell Death Dis; 2015 Oct; 6(10):e1947. PubMed ID: 26512957
[TBL] [Abstract][Full Text] [Related]
7. Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.
Coblentz PD; Ahn B; Hayward LF; Yoo JK; Christou DD; Ferreira LF
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L679-L690. PubMed ID: 30702345
[TBL] [Abstract][Full Text] [Related]
8. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
9. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
[TBL] [Abstract][Full Text] [Related]
10. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
Yabu T; Imamura S; Yamashita M; Okazaki T
J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
[TBL] [Abstract][Full Text] [Related]
12. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?
Tomiuk S; Hofmann K; Nix M; Zumbansen M; Stoffel W
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3638-43. PubMed ID: 9520418
[TBL] [Abstract][Full Text] [Related]
13. Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation.
Supinski GS; Alimov AP; Wang L; Song XH; Callahan LA
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L614-24. PubMed ID: 26138644
[TBL] [Abstract][Full Text] [Related]
14. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
[TBL] [Abstract][Full Text] [Related]
15. DOC45, a novel DNA damage-regulated nucleocytoplasmic ATPase that is overexpressed in multiple human malignancies.
Sun H; Luo X; Montalbano J; Jin W; Shi J; Sheikh MS; Huang Y
Mol Cancer Res; 2010 Jan; 8(1):57-66. PubMed ID: 20053727
[TBL] [Abstract][Full Text] [Related]
16. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N; Luberto C; Hannun YA
J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel thioredoxin-related transmembrane protein of the endoplasmic reticulum.
Haugstetter J; Blicher T; Ellgaard L
J Biol Chem; 2005 Mar; 280(9):8371-80. PubMed ID: 15623505
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo.
Stoffel W
Chem Phys Lipids; 1999 Nov; 102(1-2):107-21. PubMed ID: 11001565
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Rodríguez A; Ortiz-Ferrón G; Redondo JM; López-Rivas A
J Biol Chem; 2004 Feb; 279(6):4093-101. PubMed ID: 14623878
[TBL] [Abstract][Full Text] [Related]
20. The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase.
Won JS; Im YB; Khan M; Singh AK; Singh I
J Neurochem; 2004 Feb; 88(3):583-93. PubMed ID: 14720208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
